A novel marker integrating multiple genetic alterations better predicts platinum sensitivity in ovarian cancer than HRD score.

No significant association could be observed between any genetic alterations and patients’ pathological response as well, which was defined as whether patients achieved complete response or partial response, but borderline significance was found between copy number loss of either chromosome 5q or 4p and patients’ pathological response ( p = 0.084) ( Table 1 ).

also in 7,017 other papers